Sanofi Offers to Acquire Kiadis

Sanofi Offers to Acquire Kiadis

On 2 November 2020, Kiadis and Sanofi announced that they reached agreement on a recommended public offer by Sanofi for the entire issued and outstanding share capital of Kiadis, for an offer price of EUR 5.45 (cum dividend) per Kiadis share.

With the publication of the Offer Memorandum on 12 February 2021, the offer was launched and, as of 15 February 2021, shareholders can accept the offer by tendering their Kiadis shares. Shareholders can tender their shares until 12 April 2021, 17:40 hours CET, unless the acceptance period is extended in accordance with Section 5.10. of the Offer Memorandum. Shareholders are advised to contact their financial intermediary, who may set an earlier deadline than 12 April 2021, in order to communicate the acceptances to the Settlement Agent in a timely manner.

On 12 February 2021, the management board and supervisory board of Kiadis also published their Position Statement regarding the offer. In this document they explain why they support the offer and recommend to shareholders to accept it.

On this page you will find all information and documents related to the offer. The Offer Memorandum and the Position Statement contain important information that should be carefully read before a decision is made to tender Kiadis shares under the offer.

If there are any questions, please contact Investor Relations by email at info@kiadis.com. Retail investors can also contact SanofiofferforKiadis@georgeson.com or phone to + 31 10 313 8909.

Please find here all documents including the convocation and the agenda for the EGM scheduled on 30 March 2021.

Public offer by Sanofi

ELECTRONIC VERSIONS OF THE MATERIALS YOU ARE SEEKING TO ACCESS ARE BEING MADE AVAILABLE ON THIS WEBSITE IN GOOD FAITH AND ARE FOR INFORMATION PURPOSES ONLY.

THESE MATERIALS YOU ARE SEEKING TO ACCESS ARE NOT DIRECTED AT AND SHOULD NOT BE ACCESSED BY PERSONS RESIDENT OR LOCATED IN ANY JURISDICTION WHERE THE EXTENSION OF AVAILABILITY OF THE MATERIALS TO WHICH YOU ARE SEEKING ACCESS WOULD BREACH ANY APPLICABLE LAW OR REGULATION.

Neither the materials you are seeking to access nor any supplement thereto (the Information) constitute an offer to purchase, to acquire or to sell securities or a solicitation of an offer to purchase, to acquire or sell securities (a) in any jurisdiction in which such offer or solicitation is not authorised or (b) to any person to whom it is unlawful to make such offer or solicitation. It is the responsibility of any person wishing to access the Information to ensure that this access does not violate applicable legislation or regulations and to ensure compliance there with where appropriate.

If you are not permitted to view materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this webpage. These materials must not be released or otherwise forwarded, distributed or sent in or into any jurisdiction in which such offers or sales are unlawful. Persons receiving such documents (including custodians, nominees and trustees) must not distribute or send them in, into or from any jurisdiction in which such offers or sales are unlawful.

Confirmation of understanding and acceptance of disclaimer

I warrant that I am not resident or located in any jurisdiction where accessing these materials is unlawful, and I agree that I will not transmit or otherwise send any materials contained in this website to any person in any territory where to do so would breach applicable local law or regulation.

I have read and understood the disclaimer set out above. I understand that it may affect my rights and I agree to be bound by its terms. I confirm that I am permitted to proceed to electronic versions of the materials.